{
    "clinical_study": {
        "@rank": "3074", 
        "arm_group": {
            "arm_group_label": "lansoprazole", 
            "arm_group_type": "Experimental", 
            "description": "lansoprazole 1mg/kg twice a day for 14days"
        }, 
        "brief_summary": {
            "textblock": "This study is pilot study to evaluate safety and efficacy of lansoprazole in preterm infants\n      with gastroesophageal reflux documented by 24hr pH impedance monitoring"
        }, 
        "brief_title": "Lansoprazole in Preterm Infants With Reflux", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Preterm Infants", 
            "Gastrointestinal Reflux"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Gastroesophageal Reflux", 
                "Esophagitis, Peptic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  preterm infant\n\n          -  documented gastrointestinal reflux by 24hr pH monitoring\n\n        Exclusion Criteria:\n\n          -  unstable vital sings\n\n          -  congenital anomaly in upper gastrointestinal tract incuding esophagus\n\n          -  drug history of H2 blocker during last 1 week\n\n          -  medication of warfarin, carbamazepine, phenytoin, rifampin\n\n          -  renal or hepatic dysfunction\n\n          -  inappropriate clinical conditions judged by researchers"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "4 Months", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "5", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01778101", 
            "org_study_id": "Lanso_pilot", 
            "secondary_id": "0720120860"
        }, 
        "intervention": {
            "arm_group_label": "lansoprazole", 
            "description": "lansoprazole 1mg/kg twice a day for 14days", 
            "intervention_name": "Lansoprazole", 
            "intervention_type": "Drug", 
            "other_name": "lanston LFDT"
        }, 
        "intervention_browse": {
            "mesh_term": "Lansoprazole"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "preterm infants", 
            "reflux", 
            "impedance", 
            "pH", 
            "monitoring", 
            "lansoprazole"
        ], 
        "lastchanged_date": "September 11, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "110-740"
                }, 
                "name": "Seoul National University Children's Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Pilot Study - Lansoprazole in Preterm Infants With Gastroesophageal Reflux", 
        "overall_official": {
            "affiliation": "Seoul National University Hospital", 
            "last_name": "Han-Suk Kim, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Korea: Food and Drug Administration", 
                "Korea: Institutional Review Board", 
                "Korea: Ministry for Health, Welfare and Family Affairs"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "number of acid exposure percent time of acid exposure mean acid clearance time Acid Reflux Composite Score Analysis ; total time in reflux, episodes of 5min, composite score Bolus exposure(impedance); acid percent time, weakly acid percent time, weakly alkaline percentime Reflux Episodes activity Reflux Symptom Index Reflux Symptom Sensitivity Index Reflux Symptom Association Probability", 
            "measure": "impedance pH monitoring", 
            "safety_issue": "No", 
            "time_frame": "day14"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01778101"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Han-Suk Kim", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "apnea bradycardia desaturation regurgitate vomiting", 
                "measure": "Symtomts of reflux_d5", 
                "safety_issue": "No", 
                "time_frame": "day 5"
            }, 
            {
                "description": "number of acid exposure percent time of acid exposure mean acid clearance time Acid Reflux Composite Score Analysis ; total time in reflux, episodes of 5min, composite score Bolus exposure(impedance); acid percent time, weakly acid percent time, weakly alkaline percentime Reflux Episodes activity Reflux Symptom Index Reflux Symptom Sensitivity Index Reflux Symptom Association Probability", 
                "measure": "impedance pH monitoring_d10", 
                "safety_issue": "No", 
                "time_frame": "day10"
            }, 
            {
                "description": "number of acid exposure percent time of acid exposure mean acid clearance time Acid Reflux Composite Score Analysis ; total time in reflux, episodes of 5min, composite score Bolus exposure(impedance); acid percent time, weakly acid percent time, weakly alkaline percentime Reflux Episodes activity Reflux Symptom Index Reflux Symptom Sensitivity Index Reflux Symptom Association Probability", 
                "measure": "impedance pH monitoring_d5", 
                "safety_issue": "No", 
                "time_frame": "day5"
            }, 
            {
                "description": "apnea bradycardia desaturation regurgitate vomiting", 
                "measure": "Symtomts of reflux_d10", 
                "safety_issue": "No", 
                "time_frame": "day 10"
            }, 
            {
                "description": "apnea bradycardia desaturation regurgitate vomiting", 
                "measure": "Symtomts of reflux_d14", 
                "safety_issue": "No", 
                "time_frame": "Symtomts of reflux_d14 day 14"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}